BridgeMD
New treatment option for Psychosis
Official title Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk
ClinicalTrials.gov ID: NCT05131035
What this study is testing
- What it's testing
- This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, represents a vulnerability factor for psychosis. This remotely-delivered intervention combining targeted cognitive training exercises and group support was developed to directly impact processing speed, and at the same time, boost motivation and engagement in adolescents at risk for schizophrenia and other psychotic disorders.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 20
You may be able to join if
- Meet Clinical High Risk (CHR) criteria on the Structured Interview for Psychosis Risk Syndromes, defined by the presence of at least one attenuated...
- A score representing 0.5 SD below the mean on Animal Naming, Trails A or BACS: Symbol Coding from the MATRICS Consensus Cognitive Battery (MCCB).
You likely can't join if
- Any DSM 5 Schizophrenia-Spectrum diagnosis
- Non-English speaking
- Past or current history of a clinically significant central nervous system disorder (e.g., seizure disorder)
- Estimated IQ\<70
- Significant head injury
- Significant substance abuse
See the full eligibility criteria
- Meet Clinical High Risk (CHR) criteria on the Structured Interview for Psychosis Risk Syndromes, defined by the presence of at least one attenuated positive symptom at a moderate to severe level
- A score representing 0.5 SD below the mean on Animal Naming, Trails A or BACS: Symbol Coding from the MATRICS Consensus Cognitive Battery (MCCB).
- Any DSM 5 Schizophrenia-Spectrum diagnosis
- Non-English speaking
- Past or current history of a clinically significant central nervous system disorder (e.g., seizure disorder)
- Estimated IQ\<70
- Significant head injury
- Significant substance abuse
- Significant visual or auditory impairment.
The study team makes the final eligibility decision.
Where it's taking place
- Glen Oaks, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 20 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Glen Oaks, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.